youtube_live
Q3 2026 earnings • released • EPS beat +27.44% • Revenue beat +8.13%
See resultschevron_right
CRGY:NYSE
Crescent Energy Co
$13.47
arrow_downward
-5.11%(-0.72) 1D
$13.45
arrow_downward
-0.15% (-0.020)bedtimeAfter hours
Closed: Nov 2, 4:00:02 PM GMT-5 · USD
search
All symbols
No data
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CRGY...
Open
$13.83
High
$14.05
Low
$13.40
Mkt. cap
5.69B
Avg. vol.
9.43M
Volume
8.61M
Dividend
3.56%
Quarterly dividend
$0.12
Ex-dividend date
Aug 17, 2026
52-wk high
$15.47
52-wk low
$7.68
EPS
-$0.06
Beta
0.94
Shares outstanding
410.46M
No. of employees
1K
Open
$13.83
High
$14.05
Low
$13.40
Mkt. cap
5.69B
Avg. vol.
9.43M
Volume
8.61M
Dividend
3.56%
Quarterly dividend
$0.12
Ex-dividend date
Aug 17, 2026
52-wk high
$15.47
52-wk low
$7.68
EPS
-$0.06
Beta
0.94
Shares outstanding
410.46M
No. of employees
1K
News stories
From web sources and news partners
GuruFocus
·
1 hour ago
Crescent Energy (CRGY) Posts Q3 Loss Amid Sector Rally, Shares U
Yahoo Finance
·
2 hours ago
Crescent Energy (CRGY) Surpasses Q3 Earnings and Revenue Estimates
Seeking Alpha
·
2 hours ago
Crescent Energy files for proposed IPO of royalty subsidiary (CRGY:NYSE)
About Crescent Energy Co
CEO-
Employees1.07K
FoundedDec 7, 2021
HeadquartersHouston, Texas, United States
SectorEnergy
Websitecrescentenergyco.com
Analyst ratings
Based on 15 analysts giving stock ratings to CRGY in the past 3 months
Buy
Buy
12
Hold
2
Sell
1
12-month forecast
Based on 15 Wall Street analysts offering 12 month price targets for CRGY in the last 3 months.
Highest
Current $13.47
$21.00 (+55.90%)
Average
$17.79 (+32.07%)
Lowest
$12.00 (-10.91%)
Analyst | Recommendation | Action | Price target | Projected | Date |
|---|---|---|---|---|---|
Noah Hungness Wells Fargo | Buy | Reiterated | $20.00 | +48.5% | 10/30/2026 |
Gabriel Daoud Truist Financial | Buy | Reiterated | $19.00 | +41.1% | 10/27/2026 |
Tim Rezvan KeyBanc | Buy | Reiterated | $19.00 | +41.1% | 10/23/2026 |
Peyton Dorne UBS | Buy | Reiterated | $18.00 | +33.6% | 10/21/2026 |
Gabriele Sorbara Siebert Williams Shank & Co | Buy | Maintained | $21.00 | +55.9% | 10/19/2026 |
Mark Lear Scotiabank | Buy | Initiated | $18.00 | +33.6% | 10/14/2026 |
Unknown Analyst Scotiabank | Buy | Initiated | $18.00 | +33.6% | 10/14/2026 |
Stephen Richardson Evercore ISI | Buy | Maintained | $17.00 | +26.2% | 10/14/2026 |
Phillip Jungwirth BMO Capital | Hold | Reiterated | $16.00 | +18.8% | 09/18/2026 |
John Freeman Raymond James | Buy | Maintained | $20.00 | +48.5% | 09/10/2026 |
Hanwen Chang Wells Fargo | Buy | Maintained | $19.00 | +41.1% | 09/09/2026 |
Unknown Analyst Seaport Global | Sell | Initiated | $12.00 | -10.9% | 09/02/2026 |
Arun Jayaram J.P. Morgan | Buy | Maintained | $20.00 | +48.5% | 08/06/2026 |
John Abbott Wolfe Research | Buy | Maintained | $15.00 | +11.4% | 08/03/2026 |
William Janela Mizuho Securities | Hold | Maintained | $16.00 | +18.8% | 08/04/2026 |
Michael Scialla Stephens | Buy | Maintained | $18.00 | +33.6% | 08/04/2026 |
Neal Dingmann William Blair | Buy | Maintained | - | - | 08/03/2026 |
Sam Margolin Wells Fargo | Buy | Maintained | $18.00 | +33.6% | 07/24/2026 |
Charles Meade Johnson Rice | Buy | Maintained | $19.00 | +41.1% | 03/24/2026 |
Zach Parham J.P. Morgan | Buy | Initiated | $19.00 | +41.1% | 03/20/2026 |
Last report
Nov 3, 2026
Fiscal period
Q3 2026
- Normalized EPS / Est. (USD)
- GAAP EPS / Est. (USD)
$0.77 / $0.60
+27.44%beat
arrow_upward
Revenue / Est. (USD)
1.35B / 1.25B
+8.13%beat
arrow_upward
Fiscal Q3 2026 earnings call
youtube_liveWaiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
- Quarterly
- Annual
All values in USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
Revenue | 866.58M | 865.05M | 1.18B | 1.39B |
Cost of goods sold | 386.88M | 407.21M | 429.02M | 407.67M |
Cost of revenue | 386.88M | 407.21M | 429.02M | 407.67M |
Research and development expenses | - | - | - | - |
Total research and development expenses | - | - | - | - |
Selling, general, and admin expenses | 54.63M | 139.91M | 55.37M | 59.63M |
Operating expense | 371.91M | 410.60M | 1.12B | 236.11M |
Total operating expenses | 758.79M | 817.80M | 1.55B | 643.79M |
Operating income | 107.79M | 47.24M | -368.79M | 751.17M |
Other non operating income | 209.00K | -5.46M | -327.00K | 471.00K |
EBT including unusual items | -14.30M | 3.89M | -501.45M | 663.62M |
EBT excluding unusual items | 36.23M | -35.12M | -473.74M | 651.92M |
Income tax expense | -4.03M | -5.13M | -82.27M | 169.92M |
Effective tax rate | 28.19% | -132.01% | 16.41% | 25.60% |
Other operating expenses | -55.70M | -139.64M | 706.59M | -181.88M |
Net income | -9.51M | -8.66M | -419.85M | 492.76M |
Net profit margin | -1.10% | -1.00% | -35.50% | 35.32% |
Earnings per share | 0.35 | 0.49 | 0.53 | 0.69 |
Interest and investment income | - | - | - | - |
Interest expense | -72.63M | -77.40M | -104.57M | -99.82M |
Net interest expenses | -72.63M | -77.40M | -104.57M | -99.82M |
Depreciation and amortization charges | 298.45M | 288.82M | 354.12M | 358.00M |
EBITDA | 479.76M | 447.66M | -14.67M | 1.11B |
Gain or loss from assets sale | 1.64M | -136.41M | 2.88M | -13.57M |
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider | Position | Type | Date | Shares | Amount |
|---|---|---|---|---|---|
Page 1
Upcoming events